https://orcid.org/0000-0002-0673-7017
References
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853. doi:10.1016/S0140-6736(98)07019-6
- Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–2572.
- Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986. doi:10.1056/NEJM199309303291401
- Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non–insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103–117. doi:10.1016/0168-8227(95)01064-K
- American Diabetes Association. Standards of medical care in diabetes – 2015. Diabetes Care. 2015;38(Suppl 1):S1–S94.
- Hoerger TJ, Segel JE, Gregg EW, et al. Is glycemic control improving in US adults? Diabetes Care. 2008;31:81–86. doi:10.2337/dc07-1572
- Selby JV, Swain BE, Gerzoff RB, et al. Understanding the gap between good processes of diabetes care and poor intermediate outcomes: translating research into action for diabetes (TRIAD). Med Care. 2007;45:1144–1153. doi:10.1097/MLR.0b013e3181468e79
- Vouri SM, Shaw RF, Waterbury NV, Egge JA, Alexander B. Prevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetes. J Manag Care Pharm. 2011;17(4):304–312. doi:10.18553/jmcp.2011.17.4.304
- Menon AS, Ahluwahlia AI. The ABC of diabetes. How many patients are able to achieve the goal laid down by American diabetes association? Med J Armed Forces India. 2015;71:132–134. doi:10.1016/j.mjafi.2014.10.008
- Muzaffar F, Fatima N, Fawwad A, Riaz M. Adherence of healthcare professionals to American diabetes association 2004 guidelines for the care of patients with type 2 diabetes at peripheral diabetes clinics in Karachi, Pakistan. Pak J Med Sci. 2013;29(2):474. doi:10.12669/pjms.292.3149
- Janghorbani M, Papi B, Amini M. Current status of glucose, blood pressure and lipid management in type 2 diabetes clinic attendees in Isfahan, Iran. J Diabetes Investig. 2015;6(6):716–725. doi:10.1111/jdi.12349
- Casagrande SS, Fradkin JE, Saydah SH, et al. Prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care. 2013;36:2271–2279.
- Pinchevsky Y, Butkow N, Chirwa T, Raal FJ. Glycaemic, blood pressure and cholesterol control in 25 629 diabetics. Cardiovasc J Afr. 2015;26(4):188. doi:10.5830/CVJA-2015-050
- Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in US diabetes care, 1999–2010. N Engl J Med. 2013;368(17):1613–1624. doi:10.1056/NEJMsa1213829
- Hussain A, Ali I, Ijaz M, et al. Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia. Ther Adv Endocrinol Metab. 2017;8(4):51–57. doi:10.1177/2042018817692296
- Fung AC, Tse G, Cheng HL, et al. Depressive symptoms, co-morbidities, and glycemic control in Hong Kong Chinese elderly patients with type 2 diabetes mellitus. Front Endocrinol. 2018;9:261. doi:10.3389/fendo.2018.00261
- Elbur AI, Alasseri A, Alkhaldi M, et al. Adherence to lipid lowering drugs and level of low-density lipoprotein cholesterol among patients with type 2 diabetes, King Fahd Hospital, Al Khobar, Kingdom of Saudi Arabia. J Diab Care. 2019;1:1–2.